ABT

Abbott Laboratories
$112.47
+0.88 (+0.79%)
Mkt Cap 194.62B
Volume 7,520,601
52W Range 81.97-137.49
Sector Healthcare
Beta 0.58
EPS (TTM) 3.11 USD
P/E Ratio 36.16
Revenue (TTM) 46.59B USD
Rev Growth (5Y) +5.1%
EPS Growth (5Y) +8.2%
AlphaVal · Fair Value
What we estimate one share is worth
$55.80
Overvalued strong signal
101.6% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
B
Stable Earnings Power
72.7 / 100 composite
Steady, predictable earnings power — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 44.33B 41.95B 40.11B 43.65B 43.08B 34.61B 31.90B 30.58B 27.39B 20.85B 20.41B 20.25B
Net Income 6.52B 13.40B 5.72B 6.93B 7.07B 4.50B 3.69B 2.37B 477.00M 1.40B 4.42B 2.28B
EPS 3.74 7.67 3.30 3.94 3.97 2.52 2.07 1.35 0.27 0.95 3.00 1.51
Free Cash Flow 7.39B 6.35B 5.06B 7.80B 8.65B 5.72B 4.50B 4.91B 4.43B 2.08B 1.86B 2.60B
FCF / Share 4.23 3.67 2.92 4.45 4.87 3.23 2.54 2.79 2.54 1.41 1.26 1.72
Operating CF 9.57B 8.56B 7.26B 9.58B 10.53B 7.90B 6.14B 6.30B 5.57B 3.20B 2.97B 3.67B
Total Assets 86.71B 81.41B 73.21B 74.44B 75.20B 72.55B 67.89B 67.17B 76.25B 55.01B 44.00B 43.79B
Total Debt 15.07B 15.28B 15.87B 17.95B 19.25B 19.89B 19.10B 19.57B 27.92B 22.01B 9.00B 7.83B
Cash & Equiv 8.52B 7.62B 6.90B 9.88B 9.80B 6.84B 3.86B 3.84B 9.41B 18.62B 5.00B 4.06B
Book Value 52.13B 47.66B 38.60B 36.69B 35.80B 32.78B 31.09B 30.52B 30.90B 20.54B 21.21B 21.53B
Return on Equity 0.13 0.28 0.15 0.19 0.20 0.14 0.12 0.08 0.02 0.07 0.21 0.11
ABT News
BlackRock Inc. Raises Stock Position in Abbott Laboratories $ABT
Aug 29, 2026 12:38 AM · defenseworld.net
Why Abbott (ABT) is a Top Momentum Stock for the Long-Term
Aug 28, 2026 06:51 AM · zacks.com
AMG National Trust Bank Has $2.86 Million Holdings in Abbott Laboratories $ABT
Aug 28, 2026 12:26 AM · defenseworld.net
Abbott (ABT) Stock Sinks As Market Gains: Here's Why
Aug 27, 2026 02:51 PM · zacks.com
The FDA Just Gave Abbott a Diabetes First. Is Its Beaten-Down Stock Ready to Wake Up?
Aug 27, 2026 11:15 AM · 247wallst.com
Abbott's next-generation Amulet 360™ device receives CE Mark to treat people with atrial fibrillation at risk of stroke
Aug 27, 2026 05:00 AM · prnewswire.com
Bank of New York Mellon Corp Reduces Stock Holdings in Abbott Laboratories $ABT
Aug 27, 2026 01:39 AM · defenseworld.net
Abbott Laboratories $ABT Shares Acquired by Bank Hapoalim BM
Aug 26, 2026 12:43 AM · defenseworld.net
FDA authorizes Abbott's wearable to monitor ketone and glucose in diabetes patients
Aug 25, 2026 11:15 AM · reuters.com
Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetes
Aug 25, 2026 11:00 AM · gurufocus.com